Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

CNOOC 3Q Sales Rise

by Zacks Equity Research

October 26, 2012 | Comments : 0 Recommended this article: (0)
CEO

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Chinese offshore giant CNOOC Ltd. ( CEO - Analyst Report ) reported third quarter 2012 total revenue of 48.96 billion yuan ($7.73 billion), up almost 5.3% from the year-earlier level. Out of the total revenue, approximately 92% came from oil and liquids sales, which amounted to 45.05 billion yuan ($7.11 billion), up 5.0%. The results were driven by strong oil price realizations.

Production

China’s dominant producer of offshore crude oil and natural gas, CNOOC achieved net production of 87.8 million barrels of oil equivalent (MMBoe), up approximately 8.5% from the year-ago level. Of the total production, more than 79% was oil and liquids and the remaining 21% constituted natural gas. The positive performance was mainly attributable to contribution from the latest projects and new development wells. Overseas production and a steady performance from the already operational oil and gas fields also added to the upsurge.

The company’s gas volume dropped 8.2% to 104.7 billion cubic feet (Bcf) from the year-ago level of 114 Bcf, while its liquid production surged nearly 13.4% year over year to 69.6 million barrels in the three-month period.

Price Realizations

The company’s average realized oil price increased 2.9% year over year to $104.74 per barrel, while its realized gas price increased nearly 17.4% to $5.83 per thousand cubic feet (Mcf) from the year-ago level of $5.18 per Mcf.

Capital Expenditure

CNOOC spent 15.0 billion yuan as capital expenditure, representing an increase of 46.7% from the year-ago level.

During the quarter, CNOOC was busy drilling eight successful appraisal wells offshore China. Kenli 9-1 and Dongfang 13-2 were among them.

Guidance

For 2012, CNOOC expects to generate production volume between 335-345 MMBoe primarily driven by strong historical contribution from the fourth quarter.

Our Take

We maintain our long-term Neutral recommendation on CNOOC ADRs. We remain optimistic on CNOOC as we believe the company’s performance reflects its premium assets portfolio, excellent execution strategy, unique position as a pure oil play and potential transactions in the merger and acquisition space.

Again, CNOOC’s plan to acquire the Canadian energy producer Nexen Inc. ( ) for approximately $15.1 billion in cash would raise its proven reserves by 30%. Should the deal go through, it will be China’s biggest foreign takeover so far.

The company currently holds a Zacks #3 Rank, equivalent to a short-term Hold rating.

Read the full reports :

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.